HEMO CHINA was present at CSA & TISC 2021, this year’s edition of the Annual Scientific Session of Chinese Stroke Association (CSA) and Tiantan International
Developing and providing
innovative interventional medical
devices to improve the health and
quality of patients
Innovative interventional solutions addressing neurovascular and peripheral diseases
We have built a suite of innovative interventional medical devices targeting neuro-vascular diseases in China and the broader Asia-Pacific region. Our comprehensive portfolio of neuro-interventional medical devices covers the ischemic stroke, hemorrhagic stroke and neuro access fields.
- OEM for medical devices
- Regulatory and Market Access partnership service for APAC Markets for medical device for China companies desiring to go international or overseas companies desiring to enter China
Contact us at firstname.lastname@example.org for our services.
Our Company's Devices
Our Latest News
HEMO BIOENGINEERING LIMITED (“HEMO”), a Singapore-based medical device company with a focus on treating stroke patients, is pleased to announce that its Afentta™ intracranial thrombectomy
Big congratulations go to our HEMO CHINA subsidiary for being recognized as the 18th Top Medical Device Company in this year’s prestigious Future Healthcare VB100